On ECHEMI
Home > Drugs > Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. Suzhou Zhongkai Biopharmaceutical Factory
Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. Suzhou Zhongkai Biopharmaceutical Factory
  • Founded in:

    2006-02-14
  • Country:

    China China
  • Address:

    No. 42, Chenghu Road, Wuzhong Economic Development Zone, Suzhou
  • Tax NO.:

    913205067849747778
  • Registered Funds:

    -
  • Email:

Related Drugs
Recombinant human granulocyte-stimulating factor injection
Main ingredients: recombinant human granulocyte colony stimulating factor
Name Description Content CAS NO. Registered Holders
HumanGranulocyteColonyStimulatingFactor

This product is human granulocyte colony-stimulating factor (rhGCSF) produced by genetic recombination technology. It is one of the main cytokines regulating granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

More

This product is human granulocyte colony-stimulating factor (rhGCSF) produced by genetic recombination technology. It is one of the main cytokines regulating granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

0
Recombinant human granulocyte-stimulating factor injection
Main ingredients: recombinant human granulocyte colony stimulating factor
Name Description Content CAS NO. Registered Holders
HumanGranulocyteColonyStimulatingFactor

This product is human granulocyte colony-stimulating factor (rhGCSF) produced by genetic recombination technology. It is one of the main cytokines regulating granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

More

This product is human granulocyte colony-stimulating factor (rhGCSF) produced by genetic recombination technology. It is one of the main cytokines regulating granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

0
Recombinant human granulocyte-stimulating factor injection
Main ingredients: recombinant human granulocyte colony stimulating factor
Name Description Content CAS NO. Registered Holders
HumanGranulocyteColonyStimulatingFactor

This product is human granulocyte colony stimulating factor (rhGCSF) produced by genetic recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhGCSF is one of the main cytokines regulating granulocyte hematopoiesis in the bone marrow, selectively acting on granulocyte hematopoietic progenitor cells, promoting their proliferation and differentiation, and increasing the function of granulocyte terminally differentiated cells.

More

This product is human granulocyte colony stimulating factor (rhGCSF) produced by genetic recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhGCSF is one of the main cytokines regulating granulocyte hematopoiesis in the bone marrow, selectively acting on granulocyte hematopoietic progenitor cells, promoting their proliferation and differentiation, and increasing the function of granulocyte terminally differentiated cells.

0
Recombinant human granulocyte-stimulating factor injection
Main ingredients: recombinant human granulocyte colony stimulating factor
Name Description Content CAS NO. Registered Holders
HumanGranulocyteColonyStimulatingFactor

This product is human granulocyte colony stimulating factor (rhGCSF) produced by genetic recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhGCSF is one of the main cytokines regulating granulocyte hematopoiesis in the bone marrow, selectively acting on granulocyte hematopoietic progenitor cells, promoting their proliferation and differentiation, and increasing the function of granulocyte terminally differentiated cells.

More

This product is human granulocyte colony stimulating factor (rhGCSF) produced by genetic recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhGCSF is one of the main cytokines regulating granulocyte hematopoiesis in the bone marrow, selectively acting on granulocyte hematopoietic progenitor cells, promoting their proliferation and differentiation, and increasing the function of granulocyte terminally differentiated cells.

0
Recombinant human granulocyte-stimulating factor injection
Main ingredients: recombinant human granulocyte colony stimulating factor
Name Description Content CAS NO. Registered Holders
HumanGranulocyteColonyStimulatingFactor

This product is human granulocyte colony-stimulating factor (rhGCSF) produced by genetic recombination technology. It is one of the main cytokines regulating granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

More

This product is human granulocyte colony-stimulating factor (rhGCSF) produced by genetic recombination technology. It is one of the main cytokines regulating granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.